V. Banphavichit et al. / Tetrahedron 65 (2009) 5849–5854
5853
2.47 (3H, s, ArCH3), 1.43 (9H, s, C(CH3)3); dC (100 MHz, CDCl3)
172.2, 154.9, 136.7, 135.4, 130.9, 128.4, 126.5, 126.3, 80.1, 54.2, 52.6,
28.3, 19.4; HRMS (APCIþ): M$Naþ, found 302.1354. C15H21NO4Na
requires 302.1368; HPLC analysis: ChiralPak AD-HÒ, isocratic (n-
hexane/2-propanol¼98:2), flow 0.5 mL/min, 225 nm; minor en-
antiomer tR (R)¼30.2 min; major enantiomer tR (S)¼35.3 min,
95% ee.
225 nm; minor enantiomer tR (R)¼25.9 min; major enantiomer tR
(S)¼28.1 min, 91% ee.
4.3.8. N-Boc-(S)-4-chlorophenylglycine methyl ester [(S)-4i]
Compound (S)-4i was prepared according to the general pro-
cedure using (S)-3i as a starting material. The product was obtained
as a white solid (129.0 mg, 86%), mp 79–80 ꢀC; Rf¼0.25 (20% ethyl
28
acetate in hexanes); [
a
]
þ102.3 (c 1.0, CHCl3); nmax (KBr) 3399 (N–
D
4.3.4. N-Boc-(S)-4-methylphenylglycine methyl ester [(S)-4e]19
Compound (S)-4e was prepared according to the general pro-
cedure using (S)-3e as a starting material. The product was obtained
H), 3011, 2987, 1736 (C]O), 1697 (C]O), 1594, 1502, 1445, 1344,
1305, 1256, 1165 cmꢁ1
;
dH (400 MHz, CDCl3) 7.31 (4H, m, Ar), 5.62
(1H, br d, NHBoc), 5.28 (1H, d, J¼6.8 Hz, CHCO2Me), 3.71 (3H, s,
OCH3), 1.42 (9H, s, C(CH3)3); dC (100 MHz, CDCl3) 171.2, 154.7, 135.6,
134.3, 129.0, 128.4, 80.4, 56.9, 52.9, 28.3; HRMS (APCIþ):
[(MꢁBoc)$Hþ], found 200.0470. C9H11ClNO2 requires 200.0478;
HPLC analysis: ChiralCel ODÒ, isocratic (n-hexane/2-prop-
anol¼99:1), flow 0.5 mL/min, 225 nm; minor enantiomer tR
(R)¼17.8 min; major enantiomer tR (S)¼19.2 min, 94% ee.
as a colorless oil (83.3 mg, 60%); Rf¼0.35 (20% ethyl acetate in
28
hexanes); [
a]
þ129.2 (c 1.0, CHCl3); nmax (film) 3395 (N–H), 3054,
D
2979, 1734 (C]O), 1700 (C]O), 1505, 1444, 1349, 1317, 1251,
1170 cmꢁ1
;
dH (400 MHz, CDCl3) 7.24 (2H, d, J¼8.0 Hz, Ar), 7.15 (2H,
d, J¼8.0 Hz, Ar), 5.50 (1H, br d, NHBoc), 5.27 (1H, d, J¼6.8 Hz,
CHCO2Me), 3.71 (3H, s, OCH3), 2.33 (3H, s, ArCH3), 1.43 (9H, s,
C(CH3)3); dC (100 MHz, CDCl3) 171.8, 154.8, 138.3, 133.9, 129.7, 127.0,
80.1, 57.3, 52.6, 28.3, 21.1; HPLC analysis: ChiralCel ODÒ, isocratic (n-
hexane/2-propanol¼99:1), flow 0.5 mL/min, 225 nm; minor enan-
tiomer tR (R)¼20.9 min; major enantiomer tR (S)¼22.3 min, 92% ee.
4.3.9. N-Boc-(S)-3-fluorophenylglycine methyl ester [(S)-4j]
Compound (S)-4j was prepared according to the general pro-
cedure using (S)-4j asa startingmaterial. The product wasobtained as
a white solid (132.6 mg, 91%), mp 77–79 ꢀC; Rf¼0.34 (20% ethyl ace-
28
4.3.5. N-Boc-(S)-2-bromophenylglycine methyl ester [(S)-4f]
Compound (S)-4f was prepared according to the general pro-
cedure using (S)-3f as a starting material. The product was obtained
tate in hexanes); [
a
]
þ100.4 (c 1.03, CHCl3); nmax (KBr) 3398 (N–H),
D
3015, 2987, 1736 (C]O), 1698 (C]O), 1594, 1501, 1445, 1344, 1306,
1255, 1165 cmꢁ1
;
dH (400 MHz, CDCl3) 7.32 (1H, m, Ar), 7.15 (1H, d,
as a colorless oil (152.4 mg, 87%); Rf¼0.30 (20% ethyl acetate in
J¼7.6 Hz, Ar), 7.07 (1H, d, J¼9.6 Hz, Ar), 7.00 (1H, m, Ar), 5.70 (1H, br d,
NHBoc), 5.32 (1H, d, J¼6.8 Hz, CHCO2Me), 3.73 (3H, s, OCH3),1.43 (9H,
s, C(CH3)3); dC (100 MHz, CDCl3) 171.1, 162.6 (1JC–F¼250.0 Hz, Ar),
154.7, 139.4, 130.4 (3JC–F¼8.2 Hz), 122.8, 115.4 (2JC–F¼21.1 Hz), 114.1
(2JC–F¼22.3 Hz), 80.4, 57.1, 52.9, 28.3; HRMS (APCIþ): M$Naþ, found
306.1112. C14H18FNO4Na requires 306.1112; HPLC analysis: ChiralCel
OJ-HÒ, isocratic (n-hexane/2-propanol¼95:5), flow 1.0 mL/min,
225 nm; major enantiomer tR (S)¼8.0 min; minor enantiomer tR
(R)¼9.7 min, 87% ee.
28
hexanes); [
a
]
¼þ95.2 (c 1.0, CHCl3); nmax (film) 3379 (N–H), 3062,
D
2978, 1743 (C]O), 1715 (C]O), 1498, 1439, 1366, 1311, 1249,
1167 cmꢁ1
dH (400 MHz, CDCl3) 7.57 (1H, d, J¼7.50 Hz, Ar), 7.27–
;
7.34 (2H, m, Ar), 7.18 (1H, m, Ar), 5.70 (1H, d, J¼7.2 Hz, CHCO2Me),
5.65 (1H, br d, NHBoc), 3.72 (3H, s, OCH3), 1.42 (9H, s, C(CH3)3); dC
NMR (100 MHz, CDCl3) 171.1, 154.8, 136.8, 133.5, 129.8, 129.7, 127.9,
123.7, 80.3, 57.5, 52.9, 28.3; HRMS (APCIþ): M$Naþ, found 366.0314.
C14H18BrNO4Na requires 366.0311; HPLC analysis: ChiralCel ODÒ,
isocratic (n-hexane/2-propanol¼99:1), flow 0.5 mL/min, 225 nm;
minor enantiomer tR (R)¼29.4 min; major enantiomer tR
(S)¼32.5 min, 94% ee.
4.3.10. N-Boc-(S)-1-naphthylglycine methyl ester [(S)-4k]
Compound (S)-4k was prepared according to the general
procedure using (S)-3k as a starting material. The product was
4.3.6. N-Boc-(S)-4-bromophenylglycine methyl ester [(S)-4g]
Compound (S)-4g was prepared according to the general pro-
cedure using (S)-3g as a starting material. The product was
obtained as a colorless oil (122.6 mg, 78%); Rf¼0.31 (20% ethyl
28
acetate in hexanes); [
a
]
¼þ160.2 (c 1.0, CHCl3); nmax (film) 3377
D
(N–H), 3047, 2981, 1741 (C]O), 1692 (C]O), 1516, 1438, 1369,
1330, 1249, 1164 cmꢁ1
dH (400 MHz, CDCl3) 8.18 (1H, d, J¼8.4 Hz,
obtained as a white solid (144.0 mg, 81%), mp 86–88 ꢀC; Rf¼0.32
;
28
(20% ethyl acetate in hexanes); [
a
]
D
¼þ102.6 (c 1.0, CHCl3); nmax
Ar), 7.86 (2H, m, Ar), 7.58 (1H, apparent t, J¼7.2 Hz, Ar), 7.52 (1H,
apparent t, J¼7.4 Hz, Ar), 7.44 (2H, m, Ar), 6.09 (1H, d, J¼7.6 Hz,
CHCO2Me), 5.55 (1H, d, J¼6.8 Hz, NHBoc), 3.72 (3H, s, OCH3), 1.45
(9H, s, C(CH3)3); dC (100 MHz, CDCl3) 172.3, 155.1, 134.1, 132.8,
131.0, 129.3, 128.9, 127.0, 126.1, 125.5, 125.3, 123.3, 80.3, 54.7, 52.7,
28.3; HRMS (APCIþ): M$Naþ, found 338.1361. C18H21NO4Na re-
quires 338.1363; HPLC analysis: ChiralPak AD-HÒ, isocratic (n-
hexane/2-propanol¼90:10), flow 0.5 mL/min, 225 nm; minor
enantiomer tR (R)¼18.7 min; major enantiomer tR (S)¼21.8 min,
98% ee.
(KBr) 3392 (N–H), 3011, 2982, 1741 (C]O), 1690 (C]O), 1515, 1436,
1367, 1305, 1252, 1168 cmꢁ1
;
dH (400 MHz, CDCl3) 7.24 (2H,
d J¼8.4 Hz, Ar), 7.23 (2H, d, J¼8.4 Hz, Ar), 5.62 (1H, br d, NHBoc),
5.27 (1H, d, J¼6.8 Hz, CHCO2Me), 3.71 (3H, s, OCH3), 1.42 (9H, s,
C(CH3)3); dC (100 MHz, CDCl3) 171.1, 154.7, 136.1, 132.0, 128.8, 122.5,
80.3, 56.9, 52.9, 28.3; HRMS (APCIþ): M$Naþ, found 366.0314.
C14H18BrNO4Na requires 366.0311; HPLC analysis: ChiralCel OJ-HÒ,
isocratic (n-hexane/2-propanol¼90:10), flow 1.0 mL/min, 225 nm;
minor enantiomer tR (R)¼7.3 min; major enantiomer tR
(S)¼8.7 min, 85% ee.
4.3.11. N-Boc-(R)-1-naphthylglycine methyl ester [(R)-4k]5c
Compound (R)-4k was prepared according to the general pro-
cedure using (R)-3k as a starting material. The product was
4.3.7. N-Boc-(S)-2-chlorophenylglycine methyl ester [(S)-4h]
Compound (S)-4h was prepared according to the general pro-
cedure using (S)-3h as a starting material. The product was
obtained as a colorless oil (121.4 mg, 77%); Rf¼0.31 (20% ethyl ac-
28
obtained as a colorless oil (125.5 mg, 85%); Rf¼0.34 (20% ethyl ac-
etate in hexanes); [
a]
ꢁ160.2 (c 1.0, CHCl3); nmax (film) 3383 (N–
D
28
etate in hexanes); [
a
]
þ117.1 (c 1.0, CHCl3); nmax (film) 3376 (N–H),
H), 3051, 2977, 1746 (C]O), 1710 (C]O), 1501, 1443, 1367, 1333,
1246, 1164 cmꢁ1
dH (400 MHz, CDCl3) 8.18 (1H, d, J¼8.4 Hz, Ar),
D
3066, 2978, 1747 (C]O), 1717 (C]O), 1498, 1439, 1365, 1313, 1249,
;
1168 cmꢁ1
;
dH (400 MHz, CDCl3) 7.37 (2H, m, Ar), 7.26 (2H, m, Ar),
7.86 (2H, m, Ar), 7.60 (1H, apparent t, J¼7.6 Hz Ar), 7.54 (1H, ap-
parent t, J¼6.8 Hz, Ar), 7.43 (2H, m, Ar), 6.05 (1H, d, J¼7.6 Hz,
CHCO2Me), 5.54 (1H, br d, NHBoc), 3.72 (3H, s, OCH3), 1.45 (9H, s,
C(CH3)3); dC (100 MHz, CDCl3) 172.3, 155.0, 133.9, 132.8, 131.0, 129.3,
129.0, 127.0, 126.0, 125.5, 125.3, 123.5, 80.3, 54.7, 52.7, 28.3; HPLC
analysis: ChiralPak AD-HÒ, isocratic (n-hexane/2-propanol¼90:10),
5.68 (2H, m, CHCO2Me and NHBoc), 3.73 (3H, s, OCH3), 1.43 (9H, s,
C(CH3)3); dC (100 MHz, CDCl3) 171.1, 154.8, 135.2, 133.6, 130.1, 129.8,
129.6, 127.2, 80.3, 55.6, 52.9, 28.3; HRMS (APCIþ): M$Hþ, found
300.1003. C14H19ClNO4 requires 300.0997; HPLC analysis: ChiralCel
ODÒ, isocratic (n-hexane/2-propanol¼97:3), flow 0.3 mL/min,